8-K: Assure Holdings Sells IONM Assets to MPOWER Health for up to $4.5 Million

Assure Holdings has agreed to sell its intraoperative neuromonitoring (IONM) assets to MPOWER Health for up to $4.5 million, including a potential earnout.

Summary

• Assure Holdings Corp. has entered into an agreement to sell certain assets of its IONM business to MPOWER Health.
• The sale includes most of Assure's healthcare facility contracts, clinical equipment, and a majority of its employees.
• The total consideration for the asset sale is up to $4.5 million, with $2.5 million to be paid in cash at the initial closing.
• An additional $2.0 million may be paid as an earnout based on case volume from the acquired assets during the 12 months following the initial closing.
• Assure will retain certain assets, including accounts receivable and employees in the revenue cycle management team.
• The initial closing of the sale is expected to occur around March 22, 2024, subject to customary closing conditions and consents.
• This asset sale is part of Assure's strategic objective to repurpose its business and close its merger with Danam Health.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the strategic asset sale and the focus on the merger, but there are risks and uncertainties associated with the closing conditions and earnout payments.

Positives

• The asset sale provides Assure with a clear pathway to meet its strategic objective of repurposing its business.
• The sale is expected to facilitate the closing of the merger with Danam Health.
• MPOWER Health will continue providing IONM services to Assure's surgeon partners, maintaining continuity of care.
• The transaction provides Assure with up to $4.5 million in cash and potential future earnings.

Negatives

• Assure is selling a significant portion of its IONM business, including contracts, equipment, and a majority of its employees.
• The earnout payment of up to $2.0 million is contingent on case volume, introducing uncertainty.
• The initial closing is subject to customary closing conditions and consents, which could cause delays.

Risks

• The closing of the asset sale is subject to customary conditions and consents, which may not be met.
• The earnout payment is not guaranteed and depends on the case volume of the acquired assets.
• The merger with Danam Health is also subject to closing conditions and may not be completed.
• There are risks related to managing operating expenses and expenses associated with the proposed transactions.
• The company faces risks related to obtaining necessary governmental approvals for the transactions.
• Adjustments to the exchange ratio in the Danam merger could impact ownership percentages.
• The market price of Assure's common stock is subject to risks.
• There are potential adverse reactions or changes to business relationships resulting from the transactions.
• The combined company may face challenges in obtaining sufficient capital to advance its business plan.
• There is a risk of not realizing the anticipated benefits of the proposed transactions.

Future Outlook

The company expects the initial closing of the asset sale to occur around March 22, 2024, and is focused on completing its merger with Danam Health. The company also anticipates potential earnout payments based on the performance of the acquired assets.

Management Comments

• John Farlinger, Assure's executive chairman and CEO, stated that the sale of IONM assets to MPOWER provides Assure with a clear pathway to meet its strategic objective of repurposing the business and closing the merger with Danam Health.
• Scott LaRoque, CEO of MPOWERHealth, commented that the acquisition of Assure Neuromonitoring further solidifies their standing as a leading provider of IONM services.

Industry Context

This announcement reflects a trend of consolidation in the healthcare services sector, with MPOWER Health expanding its IONM services through acquisition. It also indicates Assure's strategic shift towards a different business model, likely focusing on the merger with Danam Health.

Comparison to Industry Standards

• The sale of assets for a combination of cash and earnout is a common structure in the healthcare industry.
• MPOWER Health's acquisition of Assure's IONM assets is similar to other strategic acquisitions aimed at expanding market share and service offerings.
• The focus on maintaining continuity of care for surgeon partners is a key consideration in healthcare acquisitions, as seen in other similar transactions.
• The valuation of the assets at up to $4.5 million is within the range of similar transactions in the neuromonitoring space, although specific comparables would require more detailed financial information.

Stakeholder Impact

• Shareholders may see a positive impact from the asset sale and the potential merger with Danam Health.
• Employees of Assure's IONM business will likely transition to MPOWER Health.
• Surgeon partners will continue to receive IONM services from the same neurophysiologists.
• Customers will experience a continuation of services under MPOWER Health.

Next Steps

• The initial closing of the asset sale to MPOWER Health is expected around March 22, 2024.
• Assure will continue to work towards completing its merger with Danam Health.
• Assure will file a registration statement on Form S-4 with the SEC in connection with the proposed merger with Danam Health.

Key Dates

Keywords

IONM, Intraoperative Neuromonitoring, Asset Sale, MPOWER Health, Merger, Danam Health, Acquisition, Healthcare, Neurology, Neurophysiologists